Commerce Bank increased its position in Aetna Inc. (NYSE:AET) by 3.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,032 shares of the company’s stock after acquiring an additional 622 shares during the period. Commerce Bank’s holdings in Aetna were worth $3,026,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of AET. FMR LLC raised its stake in Aetna by 73.8% in the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after acquiring an additional 5,833,567 shares during the last quarter. Janus Henderson Group PLC raised its stake in Aetna by 9,446.2% in the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after acquiring an additional 4,283,553 shares during the last quarter. Capital World Investors raised its stake in Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after acquiring an additional 1,688,767 shares during the last quarter. Samlyn Capital LLC purchased a new position in Aetna in the 2nd quarter worth $77,170,000. Finally, Harbour Capital Advisors LLC raised its stake in Aetna by 15,083.0% in the 2nd quarter. Harbour Capital Advisors LLC now owns 504,076 shares of the company’s stock worth $3,320,000 after acquiring an additional 500,756 shares during the last quarter. Institutional investors own 90.93% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Aetna Inc. (AET) Shares Bought by Commerce Bank” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.watchlistnews.com/aetna-inc-aet-shares-bought-by-commerce-bank/1711977.html.

Aetna Inc. (AET) traded down $1.59 during mid-day trading on Friday, reaching $173.20. The company had a trading volume of 1,750,000 shares, compared to its average volume of 2,650,000. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna Inc. has a 12 month low of $116.04 and a 12 month high of $184.98. The firm has a market cap of $55,980.00, a PE ratio of 16.83, a price-to-earnings-growth ratio of 1.57 and a beta of 0.61.

Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. During the same period in the previous year, the firm posted $2.07 EPS. Aetna’s revenue was down 5.0% compared to the same quarter last year. equities research analysts anticipate that Aetna Inc. will post 9.78 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.15%. The ex-dividend date was Wednesday, October 11th. Aetna’s payout ratio is 36.97%.

AET has been the subject of a number of research analyst reports. BMO Capital Markets raised their target price on Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research note on Friday, October 27th. Argus reiterated a “buy” rating and set a $185.00 price objective (up previously from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. Zacks Investment Research upgraded Aetna from a “hold” rating to a “strong-buy” rating and set a $184.00 price objective for the company in a research note on Wednesday, October 25th. Cantor Fitzgerald lowered Aetna from an “overweight” rating to a “neutral” rating in a research note on Thursday, October 26th. Finally, Morgan Stanley lifted their price objective on Aetna from $172.00 to $179.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Eleven analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Aetna has an average rating of “Buy” and a consensus price target of $172.36.

In related news, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the sale, the president now directly owns 64,261 shares in the company, valued at approximately $10,404,498.51. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now owns 33,563 shares in the company, valued at $5,465,734.55. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.